clinical trial · NCT05988073
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
argenx·—·active not recruiting·n = 413
Multifocal Motor Neuropathy
brief summary
This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.
started
Nov 29, 2023
primary completion
Dec 31, 2028
completion
Dec 31, 2028
last updated
Mar 16, 2026
official title
A Multicenter Prospective Longitudinal Study of Clinical Outcomes, Disease Course, Health-Related Quality of Life, and Health Care Resource Utilization in Adult Patients With Multifocal Motor Neuropathy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol